Coherus Oncology Inc (CHRS)

Sales/Maturities of Investments

$141.27M

TTM · Period ending: · USD

CHRS logo

CHRS Sales/Maturities of Investments

Latest reported$141.27M
CHRS Sales/Maturities of Investments ($0.00 → $141.27M)
High-resolution chart · PNG

CHRS sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period endingSales/Maturities of Investments (USD)
21,462,000
14,888,000
157,642,000
0
181,364,000
274,000,000
20,400,000
43,170,000
74,500,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.